Cargando…

Identification of synergistic drug combinations using breast cancer patient-derived xenografts

Compared with other breast cancer subtypes, triple-negative breast cancer (TNBC) is associated with relatively poor outcomes due to its metastatic propensity, frequent failure to respond to chemotherapy, and lack of alternative, targeted treatment options, despite decades of major research efforts....

Descripción completa

Detalles Bibliográficos
Autores principales:	Turner, Tia H., Alzubi, Mohammad A., Harrell, J. Chuck
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6992640/ https://www.ncbi.nlm.nih.gov/pubmed/32001757 http://dx.doi.org/10.1038/s41598-020-58438-0

Ejemplares similares

Live Cell Mass Accumulation Measurement Non-Invasively Predicts Carboplatin Sensitivity in Triple-Negative Breast Cancer Patient-Derived Xenografts
por: Murray, Graeme F., et al.
Publicado: (2018)

New generation breast cancer cell lines developed from patient-derived xenografts
por: Finlay-Schultz, Jessica, et al.
Publicado: (2020)

Stratification of Tamoxifen Synergistic Combinations for the Treatment of ER+ Breast Cancer
por: Zboril, Emily K., et al.
Publicado: (2023)

Separation of breast cancer and organ microenvironment transcriptomes in metastases
por: Alzubi, Mohammad A., et al.
Publicado: (2019)

Patient-derived tumour xenografts for breast cancer drug discovery
por: Cassidy, John W, et al.
Publicado: (2016)

Discovering Synergistic Compounds with BYL-719 in PI3K Overactivated Basal-like PDXs
por: Boyd, David C., et al.
Publicado: (2023)

Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograft
por: Dozmorov, Mikhail G., et al.
Publicado: (2023)

Synergistic antitumor effects of cMet inhibitor in combination with anti-VEGF in colorectal cancer patient-derived xenograft models
por: Chen, Xiangheng, et al.
Publicado: (2018)

Identification of nuclear export inhibitor-based combination therapies in preclinical models of triple-negative breast cancer
por: Rashid, Narmeen S., et al.
Publicado: (2021)

Drug responses are conserved across patient-derived xenograft models of melanoma leading to identification of novel drug combination therapies
por: Ice, Ryan J., et al.
Publicado: (2019)

Publisher Correction: Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograft
por: Dozmorov, Mikhail G., et al.
Publicado: (2023)

Synergistic effects of bevacizumab in combination with β-elemene on subcutaneous xenografts derived from HCT-116 human colon cancer cells
por: Li, Jin-Na, et al.
Publicado: (2020)

A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology
por: Guillen, Katrin P., et al.
Publicado: (2022)

A streamlined search technology for identification of synergistic drug combinations
por: Weiss, Andrea, et al.
Publicado: (2015)

Molecular profiling of patient-derived breast cancer xenografts
por: Reyal, Fabien, et al.
Publicado: (2012)

Patient-Derived Xenograft Models of Breast Cancer and Their Application
por: Murayama, Takahiko, et al.
Publicado: (2019)

Synergistic effect of a drug loaded electrospun patch and systemic chemotherapy in pancreatic cancer xenograft
por: Jun, Eunsung, et al.
Publicado: (2017)

Synergistic inhibitory effects of capsaicin combined with cisplatin on human osteosarcoma in culture and in xenografts
por: Wang, Yang, et al.
Publicado: (2018)

Genomic screening reveals ubiquitin-like modifier activating enzyme 1 as a potent and druggable target in c-MYC-high triple negative breast cancer models
por: Jacob, Sheeba, et al.
Publicado: (2022)

Combination of cyclophosphamide and double-stranded DNA demonstrates synergistic toxicity against established xenografts
por: Alyamkina, Ekaterina A, et al.
Publicado: (2015)

Patient-derived xenograft models of breast cancer and their predictive power
por: Whittle, James R, et al.
Publicado: (2015)

Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model
por: Matossian, Margarite D., et al.
Publicado: (2019)

Estrogen induces c-Kit and an aggressive phenotype in a model of invasive lobular breast cancer
por: Harrell, J. Chuck, et al.
Publicado: (2017)

Modeling anti-IL-6 therapy using breast cancer patient-derived xenografts
por: Morancho, Beatriz, et al.
Publicado: (2016)

In Vivo Modeling of Human Breast Cancer Using Cell Line and Patient-Derived Xenografts
por: Souto, Eric P., et al.
Publicado: (2022)

Synergistic Antitumorigenic Activity of Calcitriol with Curcumin or Resveratrol is Mediated by Angiogenesis Inhibition in Triple Negative Breast Cancer Xenografts
por: García-Quiroz, Janice, et al.
Publicado: (2019)

Interplay of choline metabolites and genes in patient-derived breast cancer xenografts
por: Grinde, Maria T, et al.
Publicado: (2014)

Patient-derived breast tumor xenografts facilitating personalized cancer therapy
por: Landis, Melissa D, et al.
Publicado: (2013)

Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer
por: Goetz, Matthew P., et al.
Publicado: (2017)

OR05-02 The IGFBP-3/IGFBP-3 Receptor Axis Is a New Therapeutic Target for Triple Negative Breast Cancer
por: Cai, Qing, et al.
Publicado: (2020)

Combined Use of Metformin and Everolimus Is Synergistic in the Treatment of Breast Cancer Cells
por: Wang, Yunshan, et al.
Publicado: (2015)

Combining metformin and nelfinavir exhibits synergistic effects against the growth of human cervical cancer cells and xenograft in nude mice
por: Xia, Chenglai, et al.
Publicado: (2017)

The combination of methylsulfonylmethane and tamoxifen inhibits the Jak2/STAT5b pathway and synergistically inhibits tumor growth and metastasis in ER-positive breast cancer xenografts
por: SP, Nipin, et al.
Publicado: (2015)

PSMA-Directed CAR T Cells Combined with Low-Dose Docetaxel Treatment Induce Tumor Regression in a Prostate Cancer Xenograft Model
por: Alzubi, Jamal, et al.
Publicado: (2020)

Genomic profile of metastatic breast cancer patient-derived xenografts established using percutaneous biopsy
por: Kim, Seongyeong, et al.
Publicado: (2021)

Correction to: In Vivo Modeling of Human Breast Cancer Using Cell Line and Patient-Derived Xenografts
por: Souto, Eric P., et al.
Publicado: (2022)

A novel patient-derived orthotopic xenograft (PDOX) mouse model of highly-aggressive liver metastasis for identification of candidate effective drug-combinations
por: Zhang, Zhiying, et al.
Publicado: (2020)

Landscapes of cellular phenotypic diversity in breast cancer xenografts and their impact on drug response
por: Georgopoulou, Dimitra, et al.
Publicado: (2021)

Anti-Cancer Effects of Synergistic Drug–Bacterium Combinations on Induced Breast Cancer in BALB/c Mice
por: Subramaniam, Menaga, et al.
Publicado: (2019)

SAT-130 The Intermediate Prolactin Receptor Is a Breast Cancer Oncogene
por: Grible, Jacqueline M, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mjg84c30cn86jvi13povko9hos